文献速递腹部CTMR

磁共振弹性成像在鉴别胰腺导管腺癌与炎性肿块中的附加价值

Differentiation of pancreatic ductal adenocarcinoma from inflammatory mass: added value of magnetic resonance elastography.
PubMed 文献 · Clin Radiol · 2018-06-09

回顾性纳入经组织病理学证实的56例胰腺导管腺癌与30例炎性肿块患者,评估双频(40与60 Hz)磁共振弹性成像联合增强CT或动态增强MRI的鉴别诊断效能。联合40 Hz磁共振弹性成像较单独增强CT/动态增强MRI显著提高诊断效能(AUC 0.937 vs 0.783,p<0.01),主要通过提高特异度(96.9% vs 62.1%,p=0.002)且未显著损失敏感度(90.9% vs 94.6%,p=0.727)。

要点

  • 40 Hz磁共振弹性成像联合增强CT/动态增强MRI的AUC为0.937,高于单独增强CT/动态增强MRI的0.783(p<0.01)。
  • 联合40 Hz磁共振弹性成像特异度为96.9%,高于单独增强CT/动态增强MRI的62.1%(p=0.002)。
  • 联合40 Hz磁共振弹性成像敏感度为90.9%,与单独增强CT/动态增强MRI的94.6%无显著差异(p=0.727)。

核心结论

  • 40 Hz磁共振弹性成像联合增强CT/动态增强MRI可能有助于以相对无创的方式鉴别胰腺导管腺癌与炎性肿块。

研究设计与样本

  • 回顾性研究,通过前瞻性维护的数据库识别经组织病理学证实的30例炎性肿块和56例胰腺导管腺癌患者,所有患者均接受增强CT或动态增强MRI以及40和60 Hz双频磁共振弹性成像。

诊断标准与关键数值

  • 由两名经验丰富的放射科医师共识采用五点量表评估胰腺恶性肿瘤可能性;60 Hz磁共振弹性成像、40 Hz磁共振弹性成像、增强CT/动态增强MRI、增强CT或动态增强MRI联合60和40 Hz磁共振弹性成像的诊断准确率分别为70.2%、77.4%、83.3%、75%和92.9%。

临床应用与阅片要点

  • 联合40 Hz磁共振弹性成像与增强CT/动态增强MRI较单独增强CT/动态增强MRI提高特异度(96.9% vs 62.1%,p=0.002)且敏感度无显著损失(90.9% vs 94.6%,p=0.727);联合60 Hz磁共振弹性成像与增强CT/动态增强MRI较单独增强CT/动态增强MRI未显著改变诊断效能(AUC 0.760 vs 0.783,p=0.697)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To examine whether incorporating magnetic resonance elastography (MRE) with contrast-enhanced computed tomography (CE-CT) or dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) can provide a benefit in differentiating pancreatic ductal adenocarcinoma (PDAC) from inflammatory mass (IM).

MATERIALS AND METHODS: Thirty patients with IM and 56 patients with PDAC confirmed by histopathology were identified retrospectively via a prospectively maintained database. All patients underwent CE-CT or DCE-MRI together with dual-frequency MRE at 40 and 60 Hz. A five-point scale for likelihood of pancreatic malignancy was used by two experienced radiologists in consensus. Diagnostic accuracy of CE-CT/DCE-MRI, MRE, and their combination (modeled by logistic regression analysis) was estimated using receiver operating characteristic (ROC) analysis with a leave-one-out cross validation.

RESULTS: Accuracies for determination of PDAC by 60-Hz MRE, 40-Hz MRE, CE-CT/DCE-MRI, and the combination of CE-CT or DCE-MRI and 60- and 40-Hz MRE, were 70.2%, 77.4%, 83.3%, 75%, and 92.9%, respectively. CE-CT or DCE-MRI combined with 40-Hz MRE significantly improved diagnostic performance versus CE-CT or DCE-MRI alone (area under the ROC curve [AUC]: 0.937 versus 0.783, p<0.01) by increasing specificity (96.9% versus 62.1%, p=0.002) without a significant loss of sensitivity (90.9% versus 94.6%, p=0.727), while combined CE-CT or DCE-MRI with 60-Hz MRE did not significantly change diagnostic performance versus CE-CT/DCE-MRI alone (AUC: 0.760 versus 0.783, p=0.697).

CONCLUSION: Combined assessment by 40-Hz MRE with CE-CT/DCE-MRI may help to differentiate PDAC from IM in a relatively non-invasive fashion.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Liu Y, Wang M, Ji R, et al. Differentiation of pancreatic ductal adenocarcinoma from inflammatory mass: added value of magnetic resonance elastography. Clin Radiol. 2018. PMID: 29895389. doi:10.1016/j.crad.2018.05.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。